Neuropace Statistics
NASDAQ: NPCEHealth CareMedical/Dental InstrumentsUSD
12.76+0.09 (+0.71%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Neuropace by the numbers
Neuropace has a market capitalization of $438.0 million based on 34.32M shares outstanding. With trailing EPS of $-0.57, Neuropace is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.2% below its 50-day average and 16.5% below its 200-day average.
Average daily trading volume is 170.54K shares, or about $2.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NPCE valuation vs. peer median
| Metric | NPCE | Peer median | Difference |
|---|---|---|---|
| Market cap | $437.98M | $432.54M | +1% |
| Avg. volume | 170.54K | 309.25K | -45% |
Peer median across 8 companies: CERS, RCEL, SGHT, BWAY, CARL, SI, SENS, OFIX.
Valuation
- Market cap
- $437.98M
- EPS (TTM)
- $-0.57
- Shares outstanding
- 34.32M
Price and trading
- Previous close
- 12.67
- Open
- 12.58
- Day range
- 12.58 – 13.06
- 52-week range
- 9.22 – 19.60
- 52-week change
- +19.81%
- Beta
- —
- Volume
- 127.17K
- Average volume
- 170.54K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 437.98M
- Forward Pe
- -58.67
- Eps
- -0.57
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 19.60
- Week52 Low
- 9.22
- Avg Volume
- 170.54K
- Shares Outstanding
- 34.32M
- Ma50
- 14.20
- Ma200
- 15.29
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -34.90%
- Pct From52w Low
- 38.39%